Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Merlin, Inc. specializes in developing application software solutions primarily for the healthcare sector, focusing on electronic health records (EHR) and patient management systems. The company operates in the U.S. market and is distinguished by its proprietary algorithms that enhance patient data analytics, setting it apart from traditional EHR providers.
Merlin generates revenue through a subscription-based model for its software, complemented by consulting services for implementation and ongoing support. The company's competitive advantage lies in its advanced data analytics capabilities, which provide healthcare providers with actionable insights, enhancing patient outcomes and operational efficiency.
Adoption rates of EHR systems in hospitals and clinics
Regulatory changes impacting healthcare IT requirements
Partnerships with healthcare providers for integrated solutions
Trends in healthcare spending and technology budgets
Technological disruption from emerging health tech startups
Changes in healthcare regulations that could impact software requirements
Intensifying competition from established players like Epic and Cerner
Potential market entry of large tech firms into healthcare software
High operational cash burn with negative free cash flow
Limited revenue generation impacting liquidity
moderate - The company's performance is somewhat tied to healthcare spending, which is influenced by GDP growth and consumer spending on health services.
Interest rates affect Merlin's cost of capital for potential expansions and investments, but as a software company, it is less sensitive to rate changes compared to capital-intensive industries.
minimal - The company operates with a low debt-to-equity ratio and has sufficient liquidity, reducing its reliance on credit markets.
growth - Investors are likely attracted to the potential for rapid revenue growth in the healthcare software sector.
high - The stock has shown significant volatility, evidenced by a 53.9% decline over the past year.
